Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of GLPG1972 in Healthy Men
NCT02612246Phase 1Completed
- Sponsor
- Galapagos NV
- Start
- Nov 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of GLPG1972 in osteoarthritis (OA) (4 arms), sponsored by Galapagos NV. Primary endpoints: Number of subjects with adverse events, Number of subjects with abnormal laboratory parameters and 3 more. Started Nov 2015; status: completed.
02
Drugs
GLPG1972
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02612246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02612246.